MBZ has been shown to inhibit multiple signaling pathways, including MAPK/STAT3, JNK, ELK/SFR, MYC/MAX, and NF-κB, leading to apoptosis, autophagy, and DNA damage in various types of cancer, including pancreatic cancer. The gene discussed is STAT3; the disease is pancreatic neoplasm.